These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33021637)

  • 21. The Polish Intestinal Failure Centres' consensus on the use of teduglutide for the treatment of short bowel syndrome.
    Klek S; Kunecki M; Sobocki J; Matysiak K; Karwowska K; Urbanowicz K
    Nutrition; 2017 Jun; 38():28-33. PubMed ID: 28526379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging intestinal failure with Teduglutide - A case report.
    Schlager L; Stift A; Gartner J; Hütterer E; Harpain F
    Int J Surg Case Rep; 2021 Sep; 86():106270. PubMed ID: 34418803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon-like peptide 2 analogues in the treatment of intestinal failure: A qualitative exploration of the views of patients and their families in decision making.
    Sowerbutts AM; Burden S; Griffiths J; Abraham A; Farrer K; Leahy G; Teubner A; Cloutier A; Twist K; Kelly S; Lal S
    Clin Nutr ESPEN; 2021 Aug; 44():263-269. PubMed ID: 34330477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies.
    Hill S; Carter BA; Cohran V; Horslen S; Kaufman SS; Kocoshis SA; Mercer DF; Merritt RJ; Pakarinen MP; Protheroe S; Thompson JF; Vanderpool CPB; Venick RS; Wales PW; Smith SE; Yoon M; Grimm AA
    JPEN J Parenter Enteral Nutr; 2021 Sep; 45(7):1456-1465. PubMed ID: 33305440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teduglutide for the treatment of short bowel syndrome.
    Jeppesen PB
    Drugs Today (Barc); 2013 Oct; 49(10):599-614. PubMed ID: 24191254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Bioletto F; D'Eusebio C; Merlo FD; Aimasso U; Ossola M; Pellegrini M; Ponzo V; Chiarotto A; De Francesco A; Ghigo E; Bo S
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
    Marier JF; Jomphe C; Peyret T; Wang Y
    Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Off-Label Teduglutide Therapy in Non-intestinal Failure Patients with Chronic Malabsorption.
    George AT; Li BH; Carroll RE
    Dig Dis Sci; 2019 Jun; 64(6):1599-1603. PubMed ID: 30730014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Review of real-life teduglutide experience].
    Campos Martín C; Tejera Pérez C; Virgili-Casas N; Irles-Rocamora JA
    Nutr Hosp; 2023 Aug; 40(4):886-894. PubMed ID: 37409717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teduglutide Promotes Epithelial Tight Junction Pore Function in Murine Short Bowel Syndrome to Alleviate Intestinal Insufficiency.
    Reiner J; Berlin P; Wobar J; Schäffler H; Bannert K; Bastian M; Vollmar B; Jaster R; Lamprecht G; Witte M
    Dig Dis Sci; 2020 Dec; 65(12):3521-3537. PubMed ID: 32072437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.